Three Grants to Reduce the Burden of Hepatitis in Asia Awarded
Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia
PRINCETON, N.J., Feb 18, 2012 (BUSINESS WIRE) — The Bristol-Myers Squibb Foundation has awarded three new grants to improve prevention, diagnosis and care of hepatitis B (HBV) and hepatitis C (HCV) in China and India as part of its Delivering Hope(TM): Awareness, Prevention and Care umbrella program which is committed to reducing hepatitis-related health disparities in Asia. China and India together have an estimated 123 million people chronically infected with HBV and 59 million people chronically infected with HCV, accounting for almost 50 percent of all HBV and HCV infections worldwide.
The grant recipients, which range in scope from national and regional government health, charitable non-profit and advocacy organizations, were announced at the Asian Pacific Association for the Study of the Liver (APASL) 2012 Conference in Taipei, Taiwan, where leaders in the hepatology field gathered to promote scientific advancement and education in the Asia Pacific region. Organizations and projects receiving support include:
Continue reading this entire article:
Hepatitis C Relapse Leads to Gilead Woes
East and West: Managing New Hep C Drug Side Effects